P. Minetti

发表

ST2472: a new potential antipsychotic with very low liability to induce side-effects.

G. Campiani, F. Borsini, M. A. Stasi, 2008, The international journal of neuropsychopharmacology.

Pyrrolo[1,3]benzothiazepine-based atypical antipsychotic agents. Synthesis, structure-activity relationship, molecular modeling, and biological studies.

S. Gemma, G. Campiani, S. Butini, 2002, Journal of medicinal chemistry.

Towards the development of 5-HT₇ ligands combining serotonin-like and arylpiperazine moieties.

M. Mor, G. Tarzia, W. Cabri, 2014, European journal of medicinal chemistry.

Design, synthesis, and structure-activity relationship of N-arylnaphthylamine derivatives as amyloid aggregation inhibitors.

R. Di Santo, R. Costi, S. Caccia, 2012, Journal of medicinal chemistry.

Animal models of Parkinson׳s disease: Effects of two adenosine A2A receptor antagonists ST4206 and ST3932, metabolites of 2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535).

F. Borsini, S. Pace, A. Caprioli, 2015, European journal of pharmacology.

Reversible carnitine palmitoyltransferase inhibitors with broad chemical diversity as potential antidiabetic agents.

A. Arduini, R. Conti, M. Mabilia, 2001, Journal of medicinal chemistry.

Pyrrolo[1,3]benzothiazepine-based serotonin and dopamine receptor antagonists. Molecular modeling, further structure-activity relationship studies, and identification of novel atypical antipsychotic agents.

Caterina Fattorusso, Giuseppe Campiani, Alfredo Cagnotto, 2004, Journal of medicinal chemistry.

2-n-Butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine and analogues as A2A adenosine receptor antagonists. Design, synthesis, and pharmacological characterization.

Giovanni Piersanti, Fabrizio Giorgi, Giorgio Tarzia, 2005, Journal of medicinal chemistry.

Novel atypical antipsychotic agents: rational design, an efficient palladium-catalyzed route, and pharmacological studies.

S. Gemma, G. Campiani, S. Butini, 2005, Journal of medicinal chemistry.

Polycondensed heterocycles. Part 12: An approach to the synthesis of 2-acetyl-1′-methyl-1,2,3,4-tetrahydrospiro[isoquinoline-1,4′-pyrrolidine]-2′-one

S. Gemma, G. Campiani, S. Butini, 2002 .

Synthesis of 1,1′ [11C]‐methylene‐di‐(2‐naphthol) ([11C]ST1859) for PET studies in humans

F. Dollé, O. Langer, Markus Müller, 2005 .

Divergent synthesis of novel 9-deazaxanthine derivatives via late-stage cross-coupling reactions.

M. Mor, G. Tarzia, W. Cabri, 2012, Organic & biomolecular chemistry.

Enol Carbamates as Inhibitors of Fatty Acid Amide Hydrolase (FAAH) Endowed with High Selectivity for FAAH over the Other Targets of the Endocannabinoid System

S. Dallavalle, F. Fezza, M. Maccarrone, 2010, ChemMedChem.

Synthesis of enantiomerically pure (2R, 5R) disubstituted pyrrolidines from D-mannitol

M. Marzi, D. Misiti, P. Minetti, 1992 .

Synthesis of benzo[1,2-d;3,4-d']diimidazole and 1H-pyrazolo[4,3-b]pyridine as putative A2A receptor antagonists.

G. Tarzia, M. Castorina, G. Piersanti, 2007, Organic & biomolecular chemistry.

Efficient enantioselective synthesis of (R)-(-)-carnitine from glycerol.

F. De Angelis, M. Marzi, P. Minetti, 2000, The Journal of organic chemistry.

A new group of oxime carbamates as reversible inhibitors of fatty acid amide hydrolase.

S. Dallavalle, F. Fezza, M. Maccarrone, 2010, Bioorganic & medicinal chemistry letters.

Discovery of potent inhibitors of human and mouse fatty acid amide hydrolases.

M. Brindisi, S. Gemma, G. Campiani, 2012, Journal of medicinal chemistry.

Synthesis and biological evaluation of metabolites of 2-n-butyl-9-methyl-8-[1,2,3]triazol-2-yl-9H-purin-6-ylamine (ST1535), a potent antagonist of the A2A adenosine receptor for the treatment of Parkinson's disease.

G. Tarzia, W. Cabri, F. Borsini, 2013, Journal of medicinal chemistry.

Selective Fatty Acid Amide Hydrolase Inhibitors as Potential Novel Antiepileptic Agents.

G. Di Giovanni, Simone Brogi, S. Gemma, 2021, ACS chemical neuroscience.

Potent, Metabolically Stable 2‐Alkyl‐8‐(2H‐1,2,3‐triazol‐2‐yl)‐9H‐adenines as Adenosine A2A Receptor Ligands

G. Tarzia, M. Bassi, W. Cabri, 2015, ChemMedChem.

Development of Potent Inhibitors of Fatty Acid Amide Hydrolase Useful for the Treatment of Neuropathic Pain

Simone Brogi, M. Brindisi, S. Gemma, 2018, ChemMedChem.

Synthesis of (E)-8-(3-chlorostyryl)caffeine analogues leading to 9-deazaxanthine derivatives as dual A(2A) antagonists/MAO-B inhibitors.

Walter Cabri, Daniele Pala, Giovanni Piersanti, 2013, Journal of medicinal chemistry.

Identification of a novel arylpiperazine scaffold for fatty acid amide hydrolase inhibition with improved drug disposition properties.

M. Brindisi, S. Gemma, G. Campiani, 2013, Bioorganic & medicinal chemistry letters.

ST1936 stimulates cAMP, Ca2+, ERK1/2 and Fyn kinase through a full activation of cloned human 5-HT6 receptors.

F. Bordi, H. Rhim, G. Tarzia, 2011, European journal of pharmacology.

ST 1535: a preferential A2A adenosine receptor antagonist.

K. Varani, F. Vincenzi, F. Borsini, 2006, The international journal of neuropsychopharmacology.